Literature DB >> 1785238

Anaesthesia for cardioversion--clinical experiences with propofol and thiopentone.

J E Sternlo1, M Hägerdal.   

Abstract

A 1-year population of anaesthesias for cardioversion of supraventricular tachyarrhythmias was studied. Propofol and thiopentone were used alternately for every other procedure, and the anaesthetic-, and monitoring procedures were prospectively standardized. Twenty-one thiopentone- and 23 propofol-anaesthetized patients, who had been subjected to elective cardioversions of atrial fibrillation were compared, particularly regarding possible differences in the energy requirements for cardioversion and in the time intervals to initial awakening. There were no significant differences between the two drugs in the maximum systolic blood pressure drop, in the total mean energy requirements per kg bodyweight, or in the distribution of the number of patients over the various energy levels needed for restoration of sinus rhythm. Somewhat unexpectedly, however, the mean time interval to initial awakening was significantly longer in the propofol-anaesthetized group. Apart from this minor drawback, propofol proved to be as useful an anaesthetic agent as thiopentone for the cardioversion procedure, and may be considered as an alternative drug in selected cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1785238     DOI: 10.1111/j.1399-6576.1991.tb03357.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  5 in total

Review 1.  Anaesthetic and sedative agents used for electrical cardioversion.

Authors:  Sharon R Lewis; Amanda Nicholson; Stephanie S Reed; Johnny J Kenth; Phil Alderson; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2015-03-22

Review 2.  Propofol in patients with cardiac disease.

Authors:  N R Searle; P Sahab
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

Review 3.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

4.  To evaluate dexmedetomidine as an additive to propofol for sedation for elective cardioversion in a cardiac intensive care unit: A double-blind randomized controlled trial.

Authors:  Tanveer Singh Kundra; Parminder Kaur; P S Nagaraja; N Manjunatha
Journal:  Ann Card Anaesth       Date:  2017 Jul-Sep

Review 5.  Propofol for sedation for direct current cardioversion.

Authors:  Bruna Galvão de Wafae; Rose Mary Ferreira da Silva; Henrique Horta Veloso
Journal:  Ann Card Anaesth       Date:  2019 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.